For instance, the tumor-suppressive circRNA circNDUFB2, which activates the RIG-I–MAVS innate immune pathway, has been correlated with enhanced interferon signaling and immune cell infiltration in NSCLC, implying that its expression could predict favorable responses to immunotherapy (119). The gene discussed is RIGI; the disease is neoplasm.